After enduring sharp operating and net income losses peaking in 2024, Avanos Medical reported improved profitability metrics in 2025 alongside beating earnings estimates. The company’s operational restructuring—including executive role eliminations and severance payouts—aims to streamline costs and sharpen commercial focus. Key to the turnaround is the strategic collaboration with Siemens Healthineers on integrated pain care solutions, bolstering innovation and market reach. Liquidity remains solid with a current ratio above 2, and capital allocation has become more disciplined, evidenced by sharply reduced share repurchases amid sustained net losses. Going forward, execution on partnerships and margin improvement will be critical milestones to watch.